Christopher Drinjak

Christopher specialises in assisting lawyers to enhance their skills, win new instructions, manage client relationships and augment their international networks.

He has worked in senior business development roles based in the UK and in Germany, and currently is the business development lead for the firm's Life Sciences & Healthcare industry sector.

CV

Since 2019 Senior business development manager (Life sciences and healthcare), and Senior business development manager (Disputes and investigations, IP, Commercial tech and data, and Patents), Taylor Wessing

2011 - 2018 Senior practice development manager, Industry development (Global financial institutions group), and Interim head of business development Germany, Latham & Watkins

2001 - 2011 Business development manager (Finance and capital markets), Head of London L&DR business development, and Business development manager (Litigation and dispute resolution), Clifford Chance

Karriere

2011 - 2018 Senior practice development manager, Industry development (Global financial institutions group), and Interim head of business development Germany, Latham & Watkins

2001 - 2011 Business development manager (Finance and capital markets), Head of London L&DR business development, and Business development manager (Litigation and dispute resolution), Clifford Chance

Ausbildung

2001 Masters of business administration, International University, Germany

1996 M.A. in musicology, Michigan State University, US

1994 B.A. in German and B.A. in Music Performance, Michigan State University, US

Christopher Drinjak

Expertise

Branchen

CV

Karriere

Ausbildung

Fremdsprachen

Christopher Drinjak

Expertise

Branchen

CV

Karriere

Ausbildung

Fremdsprachen

Aktuelle News & Insights

Sparen um jeden Preis oder notwendige Maßnahmen?

Proposed Amendments to the EU Medical Device Regulation

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

Impact of the new Biotech Act on Clinical Trials in the EU

"Krankenhausplanung geht Fusionskontrolle vor"

Life Sciences Legal Lens – Vol. 1

Hungary opens health data infrastructure for AI development

Promotional activities for medical devices may qualify as agency even without direct negotiation power

No claim for damages as a result of participation in clinical drug trials

Ban on “social egg freezing” declared unconstitutional

Weitere Beraterinnen und Berater

Meet me at